Antimicrobial stewardship in the outpatient parenteral antimicrobial therapy (OPAT) setting: the impact of prescription assessment by an infectious diseases specialist

被引:8
|
作者
Cassettari, Valeria [1 ]
Novato, Newton [1 ]
Flesch Onuchic, Maria Helena [1 ]
机构
[1] NotreDame Intermed Adv Outpatient Clin, Sao Paulo, SP, Brazil
来源
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES | 2021年 / 25卷 / 02期
关键词
Antimicrobial stewardship; Outpatient parenteral antibiotic therapy; Infectious diseases physician; Home health care;
D O I
10.1016/j.bjid.2021.101560
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: In recent years, the use of outpatient parenteral antimicrobial therapy (OPAT) has increased, resulting in the need to ensure its rational and adequate utilization. This article describes the implementation of an antimicrobial stewardship program in the OPAT setting by a Health Maintenance Organization (HMO) and its results. Method: An infectious disease (ID) physician made routine assessments of all home care parenteral antimicrobial requests from February to December 2019. Information on diagnosis, renal function, weight, previous antimicrobials, and microbiology were gathered during remote evaluations. Prescription changes recommended by the ID specialist were not mandatory, but implemented by the primary provider as accepted. Antibiotic consumption data was analyzed from January 2018 to December 2019. An active screening was conducted for treatment failures: two or more treatment course requirements, or death within 15 days of the evaluation were reexamined. Results: A total of 506 antimicrobial requests were assessed. The most frequent diagnoses were urinary tract infection, pneumonia, and orthopedic surgical site infection. Six percent of evaluations were not completed due to insufficient information and 12% were requests by the primary physician for initial antimicrobial guidance. Of the 416 completed prescriptions evaluations, 58% had suggested changes, including different antimicrobials (40%), treat-ment duration (25%), and route of administration (23%). There was an increase in use of teicoplanin and meropenem, and a decrease in ceftriaxone, ertapenem, cefepime, amikacin and daptomycin use. The HMO's overall parenteral antimicrobial outpatient consumption, which had shown an upward trend over the previous year, decreased after program initiation. No major adverse results were detected in patients' clinical outcomes; two treatment failures were detected and promptly corrected; no deaths attributed to antibiotic changes were detected. Conclusion: Outpatient antimicrobial stewardship, through remote assessment by an ID specialist, was effective and safe in the OPAT setting. (C) 2021 Sociedade Brasileira de Infectologia. Published by Elsevier Espana, S.L.U.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Outpatient parenteral antimicrobial therapy (OPAT) for infectious endocarditis in Spain
    Angel Goenaga, Miguel
    Kortajarena, Xabier
    Ibarguren, Oihana
    Garcia, Rebeca
    Jesus Bustinduy, Maria
    Azkune, Harkaitz
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (01) : 89 - 90
  • [2] OPAT: outpatient parenteral antimicrobial therapy
    不详
    JAC-ANTIMICROBIAL RESISTANCE, 2020, 2 (03):
  • [3] A prescription for an outpatient parenteral antimicrobial therapy (OPAT) rotation for pharmacy residents
    Mahoney, Monica V.
    Alexander, Bryan T.
    Rivera, Christina G.
    Ryan, Keenan L.
    Childs-Kean, Lindsey M.
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2021, 4 (02): : 234 - 244
  • [4] Making a case for outpatient parenteral antimicrobial therapy (OPAT)
    Seaton, R. A.
    Gilchrist, M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (08) : 1723 - 1724
  • [5] Outpatient parenteral antimicrobial therapy (OPAT) and the general physician
    Barr, D. A.
    Seaton, R. A.
    CLINICAL MEDICINE, 2013, 13 (05) : 495 - 499
  • [6] OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY OPAT outcomes in endocarditis
    Duncan, Christopher J. A.
    Barr, David A.
    Seaton, R. Andrew
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [7] Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases
    Conant, Marjorie M.
    Erdman, Sharon M.
    Osterholzer, Danielle
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (06) : 1695 - 1700
  • [8] A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT)
    Muldoon, Eavan G.
    Switkowski, Karen
    Tice, Alan
    Snydman, David R.
    Allison, Geneve M.
    INFECTIOUS DISEASES, 2015, 47 (01) : 39 - 45
  • [9] Impact of Antimicrobial Stewardship for Pediatric Outpatient Parenteral Antibiotic Therapy
    Hersh, Adam L.
    Olson, Jared
    Stockmann, Chris
    Thorell, Emily A.
    Knackstedt, Elizabeth D.
    Esquibel, Lawanda
    Sanderson, Susan
    Pavia, Andrew T.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2018, 7 (02) : E34 - E36
  • [10] Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy
    Mahoney, Monica V.
    Childs-Kean, Lindsey M.
    Khan, Parisa
    Rivera, Christina G.
    Stevens, Ryan W.
    Ryan, Keenan L.
    CURRENT INFECTIOUS DISEASE REPORTS, 2021, 23 (12)